104 related articles for article (PubMed ID: 2159969)
1. Comparison of ACTH and ACTH precursor peptides secreted by human pituitary and lung tumour cells in vitro.
Crosby SR; Stewart MF; Farrell WE; Gibson S; White A
J Endocrinol; 1990 Apr; 125(1):147-52. PubMed ID: 2159969
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid inhibition of ACTH peptides: small cell lung cancer cell lines are more resistant than pituitary corticotroph adenoma cells.
Farrell WE; Stewart MF; Clark AJ; Crosby SR; Davis JR; White A
J Mol Endocrinol; 1993 Feb; 10(1):25-32. PubMed ID: 8383976
[TBL] [Abstract][Full Text] [Related]
3. Small cell lung cancer cell lines secrete predominantly ACTH precursor peptides not ACTH.
Stewart MF; Crosby SR; Gibson S; Twentyman PR; White A
Br J Cancer; 1989 Jul; 60(1):20-4. PubMed ID: 2553086
[TBL] [Abstract][Full Text] [Related]
4. The synthesis of ACTH and related peptides by tumours.
White A; Clark AJ; Stewart MF
Baillieres Clin Endocrinol Metab; 1990 Mar; 4(1):1-27. PubMed ID: 2167656
[TBL] [Abstract][Full Text] [Related]
5. Pro-opiomelanocortin gene expression and peptide secretion in human small-cell lung cancer cell lines.
White A; Stewart MF; Farrell WE; Crosby SR; Lavender PM; Twentyman PR; Rees LH; Clark AJ
J Mol Endocrinol; 1989 Jul; 3(1):65-70. PubMed ID: 2472813
[TBL] [Abstract][Full Text] [Related]
6. ACTH precursors: biological significance and clinical relevance.
White A; Gibson S
Clin Endocrinol (Oxf); 1998 Mar; 48(3):251-5. PubMed ID: 9578811
[No Abstract] [Full Text] [Related]
7. A pituitary tumor producing high molecular weight adrenocorticotropin-related peptides: clinical and cell culture studies.
Fuller PJ; Lim AT; Barlow JW; White EL; Khalid BA; Copolov DL; Lolait S; Funder JW; Stockigt JR
J Clin Endocrinol Metab; 1984 Jan; 58(1):134-42. PubMed ID: 6315755
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and glycosylation of proopiomelanocortin by a Cushing tumor.
Miller WL; Johnson LK
J Clin Endocrinol Metab; 1982 Sep; 55(3):441-6. PubMed ID: 6284780
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of vasopressin (V3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours.
de Keyzer Y; René P; Beldjord C; Lenne F; Bertagna X
Clin Endocrinol (Oxf); 1998 Oct; 49(4):475-82. PubMed ID: 9876345
[TBL] [Abstract][Full Text] [Related]
10. Effect of tunicamycin on the synthesis, processing, and secretion of pro-opiomelanocortin peptides in mouse pituitary cells.
Budarf ML; Herbert E
J Biol Chem; 1982 Sep; 257(17):10128-35. PubMed ID: 6286640
[TBL] [Abstract][Full Text] [Related]
11. Light and electron microscopic localization of ACTH and pro-opiomelanocortin-derived peptides in human developmental and neoplastic cells.
Osamura RY; Tsutsumi Y; Watanabe K
J Histochem Cytochem; 1984 Aug; 32(8):885-93. PubMed ID: 6086743
[TBL] [Abstract][Full Text] [Related]
12. Loss of ACTH expression in cultured human corticotroph macroadenoma cells is consistent with loss of the POMC gene signal sequence.
Rees DA; Hepburn PJ; McNicol AM; Francis K; Jasani B; Lewis MD; Farrell WE; Lewis BM; Scanlon MF; Ham J
Mol Cell Endocrinol; 2002 Mar; 189(1-2):51-7. PubMed ID: 12039064
[TBL] [Abstract][Full Text] [Related]
13. Corticotrophin-like intermediary lobe peptide as a marker of alternate pro-opiomelanocortin processing in ACTH-producing non-pituitary tumours.
Vieau D; Massias JF; Girard F; Luton JP; Bertagna X
Clin Endocrinol (Oxf); 1989 Dec; 31(6):691-700. PubMed ID: 2560687
[TBL] [Abstract][Full Text] [Related]
14. Differential release of proopiomelanocortin-derived peptides from the human pituitary: evidence from a panel of two-site immunoradiometric assays.
Gibson S; Crosby SR; Stewart MF; Jennings AM; McCall E; White A
J Clin Endocrinol Metab; 1994 Apr; 78(4):835-41. PubMed ID: 8157708
[TBL] [Abstract][Full Text] [Related]
15. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
[TBL] [Abstract][Full Text] [Related]
16. The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome.
de Keyzer Y; Lenne F; Auzan C; Jégou S; René P; Vaudry H; Kuhn JM; Luton JP; Clauser E; Bertagna X
J Clin Invest; 1996 Mar; 97(5):1311-8. PubMed ID: 8636444
[TBL] [Abstract][Full Text] [Related]
17. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of galanin and adrenocorticotropic hormone in human pituitary and pituitary adenomas.
Hsu DW; Hooi SC; Hedley-Whyte ET; Strauss RM; Kaplan LM
Am J Pathol; 1991 Apr; 138(4):897-909. PubMed ID: 1707237
[TBL] [Abstract][Full Text] [Related]
19. Bromocriptine inhibits pro-opiomelanocortin mRNA and ACTH precursor secretion in small cell lung cancer cell lines.
Farrell WE; Clark AJ; Stewart MF; Crosby SR; White A
J Clin Invest; 1992 Sep; 90(3):705-10. PubMed ID: 1325994
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
